GLP-1 therapies help control blood sugar. Beyond this, research shows that these medications can reduce the risk of major ...

Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune ...

Wearable insulin pumps are offering many diabetes patients an alternative to daily injections. The devices can improve ...

Adults with diabetes who participated in telehealth visits reported similar levels of care, trust in the healthcare system, and patient-centered communication compared to those who had in-person ...

Backed by 26 ministries and GRADE evidence, PAHO's new clinical pathway could accelerate access to SGLT2 inhibitors and ...

Gestational diabetes usually disappears after birth, although patients face a higher risk of developing type 2 diabetes ...

If you have diabetes, it’s essential that you pay special attention to the health of your feet. Diabetes can increase your risk of foot problems because high blood sugar can contribute to nerve damage ...

The American Diabetes Association® (ADA) will host the 2026 Scientific Sessions from June 5-8 in New Orleans. The ADA's Scientific Sessions is the world's largest diabetes meeting, convening an ...

Rates of type 2 diabetes are rising twice as fast in younger women than older women, according to new analysis. The figure ...

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes ...

Sansum Diabetes Research Institute (SDRI) has reopened its fully remodeled and modernized facility at 2219 Bath St., marking ...